Device Firm NOVIAN Health Inc. Wraps Up $12.7 Million Series A Funding Round

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A Chicago-based biotech firm closed Dec. 31 on a $12.735 million Series A funding round led by Pittsburgh's iNetworks LLC. Novian Health Inc. is the maker of Novilase, a laser-based device for destroying tumors that is minimally invasive. The outpatient procedure is image-guided and doesn't require general anesthetic.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC